- Home
- PFBC vs MDXG Comparison
PFBC vs MDXG Comparison
Compare PFBC & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFBC
- MDXG
- Stock Information
- Founded
- PFBC 1991
- MDXG 2006
- Country
- PFBC United States
- MDXG United States
- Employees
- PFBC N/A
- MDXG N/A
- Industry
- PFBC Major Banks
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- PFBC Finance
- MDXG Health Care
- Exchange
- PFBC Nasdaq
- MDXG Nasdaq
- Market Cap
- PFBC 1.1B
- MDXG 1.1B
- IPO Year
- PFBC 1998
- MDXG N/A
- Fundamental
- Price
- PFBC $93.81
- MDXG $6.94
- Analyst Decision
- PFBC Hold
- MDXG Buy
- Analyst Count
- PFBC 3
- MDXG 1
- Target Price
- PFBC $103.67
- MDXG $12.00
- AVG Volume (30 Days)
- PFBC 64.3K
- MDXG 414.3K
- Earning Date
- PFBC 10-20-2025
- MDXG 10-29-2025
- Dividend Yield
- PFBC 3.19%
- MDXG N/A
- EPS Growth
- PFBC N/A
- MDXG N/A
- EPS
- PFBC 9.51
- MDXG 0.21
- Revenue
- PFBC $267,978,999.00
- MDXG $363,774,000.00
- Revenue This Year
- PFBC $2.56
- MDXG $12.68
- Revenue Next Year
- PFBC $3.42
- MDXG $8.18
- P/E Ratio
- PFBC $9.90
- MDXG $33.26
- Revenue Growth
- PFBC 1.62
- MDXG 6.85
- 52 Week Low
- PFBC $71.90
- MDXG $5.47
- 52 Week High
- PFBC $99.78
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- PFBC 51.23
- MDXG 46.44
- Support Level
- PFBC $94.28
- MDXG $6.81
- Resistance Level
- PFBC $95.23
- MDXG $7.14
- Average True Range (ATR)
- PFBC 1.65
- MDXG 0.19
- MACD
- PFBC -0.13
- MDXG -0.04
- Stochastic Oscillator
- PFBC 24.40
- MDXG 28.57
About PFBC Preferred Bank
Preferred Bank is a commercial bank located in California. Its products and services are divided into Personal Banking, Business Banking, and Commercial Banking which includes Checking accounts, Savings accounts, CDs, Loans and Credit, Electronic banking, and Treasury Management. It provides personalized deposit services, real estate finance, commercial loans, and trade finance credit facilities to small and mid-sized businesses and their owners, entrepreneurs, real estate developers and investors, professionals, and high-net-worth individuals. The bank generates a majority of its revenue from Southern and Northern California and Flushing.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.